Author:
Molines Elicia,Haffner Aurélie,Fina Frédéric,Malissen Nausicaa,Ouafik L’Houcine,Grob Jean-Jacques,Macagno Nicolas
Subject
Pathology and Forensic Medicine
Reference16 articles.
1. FDA approval summary: vemurafenib for treatment of unresectable or metastatic melanoma with the BRAFV600E mutation;Kim;Clin Cancer Res,2014
2. Dabrafenib: First Global Approval;Ballantyne;Drugs,2013
3. [Development of molecular analysis by digital PCR for clinical practice: positioning, current applications and perspectives];Denis;Ann Biol Clin (Paris),2019
4. Development of digital PCR molecular tests for clinical practice: principles, practical implementation and recommendations;Denis;Ann Biol Clin (Paris),2018
5. Decalcification can cause the failure of BRAF molecular analyses and anti-BRAFV600E VE1 immunohistochemistry;Bourhis;Pathology International,2019